StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.13−0.27 (-1.75%)

Close on Nov 18, 2026Market cap $2.03BP/E 6.6Yield –

Aurinia Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Aurinia Pharmaceuticals's pe ratio was 7.1× on Nov 11, 2026, against 28.8× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.1×−21.4
2025Dec 31, 202528.5×–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?